Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class

被引:188
作者
Binda, C
Hubálek, F
Li, M
Herzig, Y
Sterling, J
Edmondson, DE
Mattevi, A
机构
[1] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
[3] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy
[4] Teva Pharmaceut Ind, Div Res & Dev, Netanya, Israel
关键词
D O I
10.1021/jm031087c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidation of arylalkylamine neurotransmitters. The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been determined at a resolution of better than 2.1 A. Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity. N-Propargyl-1(S)aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain. Four ordered water molecules are an integral part of the active site and establish H-bond interactions to the inhibitor atoms. These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline molecular scaffold.
引用
收藏
页码:1767 / 1774
页数:8
相关论文
共 27 条
[1]  
Abu-Raya S, 1999, J NEUROSCI RES, V58, P456, DOI 10.1002/(SICI)1097-4547(19991101)58:3<456::AID-JNR12>3.0.CO
[2]  
2-S
[3]  
[Anonymous], ACTA CRYSTALLOGR D
[4]   Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].
Binda, C ;
Newton-Vinson, P ;
Hubálek, F ;
Edmondson, DE ;
Mattevi, A .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26
[5]   Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures [J].
Binda, C ;
Li, M ;
Hubálek, F ;
Restelli, N ;
Edmondson, DE ;
Mattevi, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (17) :9750-9755
[6]  
Cesura A M, 1992, Prog Drug Res, V38, P171
[7]  
Desiraju G. R., 1999, WEAK HYDROGEN BOND S
[8]   Further additions to MolScript version 1.4, including reading and contouring of electron-density maps [J].
Esnouf, RM .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 :938-940
[9]  
Finberg JPM, 1996, J NEURAL TRANSM-SUPP, P95
[10]   Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues [J].
Hubálek, F ;
Binda, C ;
Li, M ;
Herzig, Y ;
Sterling, J ;
Youdim, MBH ;
Mattevi, A ;
Edmondson, DE .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1760-1766